Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 49Lung Neoplasms 30Colorectal Neoplasms 23Prostatic Neoplasms 20Colonic Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Rectal Neoplasms 13Neoplasms 13Uterine Cervical Neoplasms 12Endometrial Neoplasms 9Depression 9Unspecified Adult Solid Tumor, Protocol Specific 8Fatigue 8Anxiety Disorders 8Urinary Bladder Neoplasms 7Lymphoma 7Breast Carcinoma In Situ 7Pancreatic Neoplasms 6Pain 6Ovarian Neoplasms 6Hematologic Neoplasms 6Obesity 5Melanoma 5Hematopoietic and Lymphatic System Neoplasm 5Carcinoma, Ovarian Epithelial 5Vulvar Neoplasms 4Papillomavirus Infections 4Neoplasm Metastasis 4Multiple Myeloma 4Leukemia, Myeloid, Acute 4

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Induced Peripheral Neuropathy × Early Intervention, Educational × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡